OmniAb, Inc. (OABI)
1.725
+0.02
(+1.47%)
USD |
NASDAQ |
Feb 23, 09:42
OmniAb EPS Diluted (Quarterly) : -0.144 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| GT Biopharma, Inc. | -0.8268 |
| Foghorn Therapeutics, Inc. | -0.2514 |
| Recursion Pharmaceuticals, Inc. | -0.363 |
| Erasca, Inc. | -0.1079 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -16.52M |
| Revenue (Quarterly) | 2.239M |
| Total Expenses (Quarterly) | 18.76M |
| Enterprise Value | 206.29M |
| Gross Profit Margin (Quarterly) | -109.2% |
| Profit Margin (Quarterly) | -738.1% |
| Earnings Yield | -34.24% |
| Normalized Earnings Yield | -33.81 |